Languages
Pages
Legal
Explore all categories to find your favorite topic
New generation DES: which role in ACS?METCARDIO, Ospedaletti, Italy www.metcardio.org Why could drug-eluting stents possibly be safer than bare-metal stents? The case for
Microsoft PowerPoint - 1.Young-Keun AhnAcute Myocardial InfarctionAcute Myocardial Infarction YoungkeunYoungkeun AhnAhn, MD, PhD, MD, PhD Heart CenterHeart Center ChonnamChonnam
1. Ajay J. Kirtane, MD, SMCenter for Interventional Vascular TherapyColumbia University Medical Center /New York Presbyterian HospitalDrug-Eluting Stents forMultivessel PCI:Indications…
Drug Eluting Versus Bare Metal Stents Prof. Dr. Raouf Mahran ;MRCP Prof. of cardiovasc. Med National Heart Institute 2009 Evolution of PCI 1977: Balloon Angioplasty (POBA)…
__________ (acronym) TrialM Leon, TCT 2006 Valgimigli M et al. JAMA 2005; 293:2109-2117. 2. Spaulding C et al. NEJM 2006; 355:1093-104. 3. Menichelli M. EuroPCR 2006. 4.
Bare Metal and Drug Eluting Stents Bare Metal vs Drug Eluting Stents Should DES be the chosen one? Class 22, 1st year Adviser: Prof. Filipa Almeida Authors: Aguiar, A.; Alves,…
Sirolimus-eluting Stents: Present and Future Dr Steve Fearn Director of Health Economics and Medical Affairs Cordis UK Conflict of Interest I am employed by Cordis. Topics…
PowerPoint Presentation Drug Eluting Coronary Stent Coatings Part 10: Drug Eluting Heart Stent Coatings 1 Copyright ©1996 American Heart Association Edelman, E. R. et al.…
review article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 3683 nejm.org january 17, 2013254 Drug Therapy Drug-Eluting Coronary-Artery Stents Giulio…
Hindawi Publishing Corporation ISRN Cardiology Volume 2013 Article ID 748736 8 pages http:dxdoiorg1011552013748736 Review Article Risk Factors for Coronary Drug-Eluting Stent…
- 1 - This is a self-archived preprint version of P. K. Bowen, R. J. Guillory II, E. R. Shearier, J.-M. Seitz, J. Drelich, M. Bocks, F. Zhao, and J. Goldman, “Metallic…
HEAD OFFICE: 5751 Copley Drive Suite B San Diego CA 92111 • +1 858 966-3000 • +1 858 966-3099 FAX • wwwrevamedicalcom AUSTRALIAN OFFICE: Level 6 175 Macquarie Street…
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease The new england…
Slide 1Prospective, Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A. Byrne, Julinda…
Drug Eluting Stents overhyped, overused and overpriced? William Wijns MD, PhD Cardiovascular Center Aalst http://www.cardio-aalst.be [email protected] Advanced…
Prepared by: Michel Cucherat, MD, PhD Faculté de médecine Laennec Lyon, France [email protected] Drug eluting stents A systematic review and meta-analysis of randomized…
1. Issue date: July 2008Review date: April 2009Drug-eluting stents for thetreatment of coronary arterydisease Part review of NICEtechnology appraisal guidance 71NICE technology…
1. Solaci 2012Update on the Current Status of Enduring DES Alexandre Abizaid, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil Columbia University…
Cardiovascular Outcomes in Patients with Drug Eluting Stents Undergoing Non-cardiac Surgery Boston Scientific Interventional Fellow, Royal Jubilee Hospital, Victoria, British…
DRAFT Contains Nonbinding Recommendations Draft â Not for Implementation 6255companion.doc 4/7/2008 Guidance for Industry Coronary Drug-Eluting Stents â Nonclinical and…